Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ndividualized and Combined Effects of Diabetes and Smoking on the Antiplatelet Activity of Ticagrelor in Acute Myocardial Infarction Patients Undergoing Primary PCI

NCT05911659 is registered in ClinicalTrials.gov with Mina Wageh Mohareb as lead sponsor.

NCT NCT05911659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05911659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ndividualized and Combined Effects of Diabetes and Smoking on the Antiplatelet Activity of Ticagrelor in Acute Myocardial Infarction Patients Undergoing Primary PCI
Lead sponsor
Mina Wageh Mohareb
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2023
Completion date
June 15, 2023
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

individualized and combined effects of smoking and diabetes on the antiplatelet activity in patients undergoing primary percutaneous coronary intervention